Acute diarrhoea in dogs: probiotic preparations vs placebo — POSSIBLE

In dogs with acute diarrhoea, do defined probiotic preparations shorten duration of diarrhoea vs placebo?

Shelf #164 · gate-verified and displayed under the developer's blinded-trial rule

POSSIBLE: Defined probiotic preparations probably shorten acute diarrhoea in dogs by a modest amount — on the order of half a day to a day in a self-limiting illness — but the trials test different products and do not all agree. In the largest trial, a multicenter, double-blinded, placebo-controlled, randomized study of an Enterococcus faecium probiotic paste (Pro-Kolin Advanced) in 148 client-owned dogs, median duration of diarrhoea was 32 hours on the paste vs 47 hours on placebo (P = .008), with a relative rate of resolution 1.60 times faster on the paste (Nixon 2019). A small single-centre randomised double-blind trial found mean time to last abnormal stools of 1.3 days on a multi-strain probiotic cocktail vs 2.2 days on placebo (P = 0.04; Herstad 2010). Against those, a randomised double-blinded placebo-controlled trial of a different probiotic combination in 60 dogs found no statistically significant difference from placebo (3.5 vs 4.8 days to acceptable faecal consistency; P = 0.17 for the overall comparison; Shmalberg 2019). Because each product was tested separately, this stamp covers the preparations trialled, not probiotics as a class. Drafted Nov 10, 2026 (VetMed build, topic #164); all figures from abstracts fetched and verified at drafting.

Nixon 2019: Enterococcus faecium probiotic paste (Pro-Kolin Advanced) shortened acute diarrhoea — median 32 vs 47 hours on placebo (P = .008)

Randomized, placebo-controlled, double-blinded clinical study (record's own title wording); multicenter clinical field study

Who: Dogs: 148 client-owned dogs with acute diarrhea as the main clinical sign, in a double-blinded, placebo-controlled, randomized, blocked, multicenter clinical field study conducted at 14 primary care veterinary practices in the United Kingdom and Ireland. The anti-diarrheal probiotic paste (ADPP) contained Enterococcus faecium 4b1707.

Result: Dogs in the ADPP group had a significantly shorter duration of diarrhea than placebo (ADPP: median, 32 hours; 95% confidence interval [CI], 2–118; n = 51; Placebo: median, 47 hours; 95% CI, 4–167; n = 58; P = .008) — an absolute difference in medians of 15 hours — and the relative rate of resolution of diarrhea was 1.60 times faster in the ADPP group than in the placebo group (relative ratio, 1.60; 95% CI, 1.08–2.44; P = .02). Fewer dogs required additional medical intervention (AMI) for non-improvement or worsening in the ADPP group compared to the placebo group (3.5% of dogs, 2/57 dogs, and 14.8% of dogs, 9/61 dogs, respectively), with a relative risk of 0.88 as printed in the record (P = .04; 95% CI, 0.77–0.99).

Watch out: The analysis denominators (n = 51 and n = 58 for duration; 57 and 61 for additional intervention) are smaller than the 148 dogs enrolled, so attrition sits inside these figures. The record's printed relative risk for additional medical intervention (0.88) sits oddly against its own absolute rates (3.5% vs 14.8%); the absolute rates are the figures to rely on, and the printed relative risk is reproduced here exactly as the record gives it. The study was funded by ADM Protexin Ltd, which manufactures Pro-Kolin Advanced, and the first author was its employee, per the record's conflict-of-interest statement — normal for a licensure-style field trial, but it belongs on the face of the card.

Nixon SL, Rose L, Muller AT. Efficacy of an orally administered anti-diarrheal probiotic paste (Pro-Kolin Advanced) in dogs with acute diarrhea: A randomized, placebo-controlled, double-blinded clinical study. J Vet Intern Med. 2019;33(3):1286-1294. PMID: 30882953. Registry ID: none in the record. MeSH: Animals · Diarrhea · Dog Diseases · Dogs · Double-Blind Method · Enterococcus faecium · Female · Ireland · Male · Probiotics · Random Allocation · United Kingdom

Herstad 2010: multi-strain probiotic cocktail shortened time to last abnormal stools — mean 1.3 vs 2.2 days on placebo (P = 0.04)

Randomised, double blind, single centre study with stratified parallel group design (record's own Methods wording); indexed as Randomized Controlled Trial

Who: Dogs: 36 dogs suffering from acute diarrhoea or acute diarrhoea and vomiting, in a randomised, double blind and single centre study; animals were allocated to equal looking probiotic or placebo treatment by block randomisation with a fixed block size of six. The probiotic cocktail consisted of thermo-stabilised Lactobacillus acidophilus and live strains of Pediococcus acidilactici, Bacillus subtilis, Bacillus licheniformis and Lactobacillus farciminis.

Result: The time from initiation of treatment to the last abnormal stools was significantly shorter (P = 0.04) in the probiotic group compared to the placebo group; the mean time was 1.3 days and 2.2 days, respectively — an absolute difference of 0.9 days. The two groups were found nearly equal with regard to time from start of treatment to the last vomiting episode. The authors conclude the probiotic tested may reduce the convalescence time in acute self-limiting diarrhoea in dogs.

Watch out: Only 36 dogs, single centre, and the P value (0.04) is close to the significance line — a fragile positive. The product is a specific multi-strain cocktail, not the Enterococcus faecium paste of Nixon 2019: the draft anchor described this trial as an 'enterococcus' trial, but the record's cocktail contains no Enterococcus strain — the enterococcus product is Nixon's. Results for one preparation do not transfer to another.

Herstad HK, Nesheim BB, L'Abée-Lund T, Larsen S, Skancke E. Effects of a probiotic intervention in acute canine gastroenteritis--a controlled clinical trial. J Small Anim Pract. 2010;51(1):34-8. PMID: 20137007. Registry ID: none in the record. MeSH: Acute Disease · Animals · Bacillus · Diarrhea · Dog Diseases · Dogs · Double-Blind Method · Female · Gastroenteritis · Lactobacillus · Male · Pediococcus · Probiotics · Time Factors · Treatment Outcome

Shmalberg 2019: a different probiotic combination did not significantly beat placebo — 3.5 vs 4.8 days to acceptable faecal consistency (overall P = 0.17)

Randomized double blinded placebo-controlled clinical trial (record's own title and abstract wording)

Who: Dogs: 60 dogs without concurrent comorbidities, presenting with acute diarrhea, randomized into three treatment groups — a probiotic combination, oral metronidazole, or placebo; time to resolution of diarrheal signs was evaluated using owner surveys and fecal scoring charts.

Result: Dogs presenting with acute diarrhea achieved acceptable fecal consistency after 3.5 ± 2.2 days when receiving probiotic, 4.6 ± 2.4 days with oral metronidazole, and 4.8 ± 2.9 days with placebo; statistically significant differences were not identified between treatment groups (p = 0.17). The authors conclude the findings failed to provide evidence for the common use of metronidazole in this cohort, and that a larger study population would be required to identify a statistically significant effect of probiotics.

Watch out: This null trial used yet another probiotic combination, in 60 dogs split across three arms — it neither confirms nor refutes the specific products in the other two cards, and it was not powered to detect the modest effect those trials reported. The record carries no MeSH terms and is not indexed as a Randomized Controlled Trial (its publication types are Case Reports and Journal Article); the randomised, double-blinded, placebo-controlled design is established by the article title and abstract wording only.

Shmalberg J, Montalbano C, Morelli G, Buckley GJ. A Randomized Double Blinded Placebo-Controlled Clinical Trial of a Probiotic or Metronidazole for Acute Canine Diarrhea. Front Vet Sci. 2019;6:163. PMID: 31275948. Registry ID: none in the record. MeSH: none in the record.

Synthesis: two positives and one null, three different products — a modest, product-specific shortening of a self-limiting illness

Synthesis

Who: Synthesis of the cards above: Nixon 2019 (randomized, placebo-controlled, double-blinded, multicenter; 148 dogs enrolled; Enterococcus faecium paste), Herstad 2010 (randomised, double blind, single centre; 36 dogs; multi-strain Lactobacillus/Pediococcus/Bacillus cocktail), and Shmalberg 2019 (randomized, double blinded, placebo-controlled; 60 dogs in three arms; a different probiotic combination).

Result: The direction is consistent where effects were found — about 15 hours shorter median duration in the largest trial and 0.9 days shorter mean time to last abnormal stools in the smallest — and the one null trial pointed the same way numerically (3.5 vs 4.8 days) without reaching significance. That pattern supports POSSIBLE for the trialled preparations: a real but modest acceleration of recovery in acute, uncomplicated, self-limiting diarrhoea, not a cure and not a class effect that can be extended to untested products. No card here addresses acute haemorrhagic diarrhoea syndrome, chronic diarrhoea, or diarrhoea with systemic illness.

Watch out: All three illnesses studied were acute and self-limiting — most dogs recover in days on placebo too (47 hours median in Nixon; 4.8 days mean in Shmalberg) — so the practical question is whether roughly half a day to a day of faster resolution, and fewer additional interventions in Nixon (3.5% vs 14.8%), is worth the product's cost in an individual case.

Synthesis of Nixon SL et al. PMID: 30882953; Herstad HK et al. PMID: 20137007; Shmalberg J et al. PMID: 31275948. Registry IDs as on the individual cards.

Back to the library index · VetMed home

VetMed is an educational resource, not veterinary advice.